StonvexLoading…
StonvexCore line items from ENB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | C$8.97B | C$29.33B | C$21.48B | C$15.33B |
Operating Income | C$3.23B | C$10.96B | C$2.27B | C$2.29B |
Net Income | C$1.78B | C$7.49B | C$788.00M | C$2.28B |
EPS (Diluted) | C$0.76 | C$3.22 | C$0.30 | C$1.00 |
Total Assets | C$228.20B | C$218.47B | C$216.97B | C$211.59B |
Total Liabilities | C$159.71B | C$152.55B | C$148.16B | C$143.23B |
Cash & Equivalents | C$1.64B | C$1.09B | C$1.41B | C$1.20B |
Free Cash Flow OCF − CapEx | C$-97.00M | C$3.30B | C$3.21B | C$2.67B |
Shares Outstanding | 2.18B | 2.18B | 2.18B | 2.18B |